SSO/ASTRO/ASCO Consensus Guideline on Margins for Breast Conserving Surgery (BCS) with Whole Breast Irradiation in Ductal Carcinoma in Situ (DCIS)
Published: September 2016/Affirmed 2019
Read Full-Text Guideline
Affirmed September 2019: Since this guideline was published more than three to five years ago, the guideline development panel evaluated the content for currency, accuracy and validity. Based on their recommendation, the SSO, ASTRO and ASCO have affirmed that an update to the guideline is not required.
This collaborative guideline focuses on several elements of optimal margin negative margin width for DCIS treated with breast-conserving surgery and whole breast irradiation. It defines positive margins and provides recommendations on negative margin width. It also discusses the impact on negative margin width of treatment with excision alone or with endocrine therapy; patient and tumor features; and DCIS in presence of invasive breast cancer. The role of margin width in choice of technique, fractionation and boost dose for whole breast irradiation is also covered.
Developed in collaboration with:
- American Society for Radiation Oncology
- American Society of Clinical Oncology
- Society of Surgical Oncology
Endorsed by:
American Society of Breast Surgeons
Key Points:
- Determination of optimal margin width to minimize risk of ipsilateral breast tumor recurrence
- Whole breast radiation therapy in combination with excision
- Excision alone
- Endocrine therapy
- Consideration of unfavorable risk factors in determining margin width
- Choice of WBRT delivery technique, fractionation and boost dose
- Considerations for DCIS with microinvasion when determining optimal margin width
Resources:
